These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 10097979)

  • 1. [A 73-year-old patient with hypertensive crisis. Was the use of calcium antagonist nifedipine justified?].
    Wenzel UO; Pfalzer B; Meinertz T; Stahl RA
    Internist (Berl); 1999 Feb; 40(2):205-9. PubMed ID: 10097979
    [No Abstract]   [Full Text] [Related]  

  • 2. Nifedipine in patients with heart disease.
    Phillips RA; Krakoff LR
    Circulation; 1996 Apr; 93(7):1474-5. PubMed ID: 8641043
    [No Abstract]   [Full Text] [Related]  

  • 3. Nifedipine trials.
    Rafflenbeul W
    Circulation; 1996 Apr; 93(7):1473-4. PubMed ID: 8641042
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrections to the nifedipine meta-analysis.
    Furberg CD; Psaty BM
    Circulation; 1996 Apr; 93(7):1475-6. PubMed ID: 8641044
    [No Abstract]   [Full Text] [Related]  

  • 5. Should a moratorium be placed on sublingual nifedipine capsules given for hypertensive emergencies and pseudoemergencies?
    Grossman E; Messerli FH; Grodzicki T; Kowey P
    JAMA; 1996 Oct 23-30; 276(16):1328-31. PubMed ID: 8861992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The FDA's decisions regarding new indications for approved drugs. Where's the evidence?
    Winker MA
    JAMA; 1996 Oct 23-30; 276(16):1342-3. PubMed ID: 8861995
    [No Abstract]   [Full Text] [Related]  

  • 7. [Slow release nifedipine in treatment of hypertension. 24-hour effect on blood pressure and heart rate--treatment follow-up of 391 patients].
    Bühler G; Wadepuhl M; Nandi K; Rosenthal J
    Fortschr Med; 1997 Aug; 115(24):37-8. PubMed ID: 9410819
    [No Abstract]   [Full Text] [Related]  

  • 8. The use of sublingual nifedipine: a continuing concern.
    Messerli FH; Grossman E
    Arch Intern Med; 1999 Oct; 159(19):2259-60. PubMed ID: 10547164
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical features and up-to-date therapy of hypertensive emergencies].
    Meyer FP
    Dtsch Med Wochenschr; 2004 Apr; 129(14):768; author reply 768-9. PubMed ID: 15042498
    [No Abstract]   [Full Text] [Related]  

  • 10. [The clinical efficacy of the calcium antagonist amlodipine in patients with ischemic heart disease and arterial hypertension].
    Zviagina TV
    Lik Sprava; 2000; (5):114-7. PubMed ID: 11031470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness analysis of hypertension treatment: controlled release nifedipine and candesartan low-dose combination therapy in patients with essential hypertension--the Nifedipine and Candesartan Combination (NICE-Combi) Study.
    Fujikawa K; Hasebe N; Kikuchi K;
    Hypertens Res; 2005 Jul; 28(7):585-91. PubMed ID: 16335887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controlled release nifedipine and valsartan combination therapy in patients with essential hypertension: the adalat CR and valsartan cost-effectiveness combination (ADVANCE-combi) study.
    Saito I; Saruta T;
    Hypertens Res; 2006 Oct; 29(10):789-96. PubMed ID: 17283866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tachycardia, orthostatic hypotension and profound weakness due to concomitant use of fluoxetine and nifedipine.
    Azaz-Livshits TL; Danenberg HD
    Pharmacopsychiatry; 1997 Nov; 30(6):274-5. PubMed ID: 9442553
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Replacement of Amlodipine and Lercanidipine by Barnidipine: Tolerability and Effectiveness in a Real-Life Study.
    Lins R; Haerden Y; de Vries C
    High Blood Press Cardiovasc Prev; 2017 Mar; 24(1):29-36. PubMed ID: 28058623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of barnidipine 10 or 20 mg plus losartan 50-mg combination versus losartan 100-mg monotherapy in patients with essential hypertension not controlled by losartan 50-mg monotherapy: A 12-week, multicenter, randomized, open-label, parallel-group study.
    Parati G; Giglio A; Lonati L; Destro M; Ricci AR; Cagnoni F; Pini C; Venco A; Maresca AM; Monza M; Grandi AM; Omboni S
    Clin Ther; 2010 Jul; 32(7):1270-84. PubMed ID: 20678675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A potential risk of sublingual nifedipine treatment in surgically treated patients in Japan.
    Kobayashi E; Kitoh Y; Fujimura A
    Crit Care Med; 1998 Jul; 26(7):1293. PubMed ID: 9671385
    [No Abstract]   [Full Text] [Related]  

  • 17. [Emergency checklist in hypertensive crisis].
    Füessl HS
    MMW Fortschr Med; 2006 Jun; 148(25):49. PubMed ID: 16859163
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluation of the effect of the sublingually administered nifedipine and captopril via transcranial doppler ultrasonography during hypertensive crisis.
    Gemici K; Baran I; Bakar M; Demircan C; Ozdemir B; Cordan J
    Blood Press; 2003; 12(1):46-8. PubMed ID: 12699135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Compliance and antihypertensive efficacy of amlodipine compared with nifedipine slow-release.
    Mounier-Vehier C; Bernaud C; Carré A; Lequeuche B; Hotton JM; Charpentier JC
    Am J Hypertens; 1998 Apr; 11(4 Pt 1):478-86. PubMed ID: 9607387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute Generalized Exanthematous Pustulosis Secondary to Nifedipine.
    Shrestha A; Rizzo V
    S D Med; 2016 May; 69(5):199-201. PubMed ID: 28863416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.